Search

everythinglearnresearchcommunity

for

Search:↓

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Taxifolin from Rhododendron mucronulatum may help prevent hair loss and promote hair growth.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride improves hair growth in men with androgenetic alopecia.

Testosterone may slow down wound healing and increase inflammation.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride reduces hair growth and is safe for women with excessive hair.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.